Olo Dcf Valuationv1.0.0

A private equity firm evaluates a manufacturing target with stable historical revenue and 8% EBITDA margins. The DCF model uses a 10-year projection period, applies a 5% CapEx assumption, and calculates WACC using a relevered beta from public comparables. Sensitivity analysis tests WACC from 9% to 13% against terminal growth rates of 2-4% to derive an enterprise value range.

A technology corporation assesses a high-growth SaaS target with 30% revenue growth and 25% EBITDA margins. The model uses a 5-year projection, 3% CapEx assumption, and exit multiple method with an EV/EBITDA multiple of 15x. It includes a 30% control premium and separately models $50M in cost synergies, presenting valuations with and without synergies.

An Asian conglomerate values a retail chain in Singapore, applying a 17% tax rate per jurisdiction. Revenue projections assume declining growth toward terminal, with WACC calculated using a 2% size premium for mid-market. The analysis flags terminal growth exceeding 3% and includes a football field chart comparing DCF to comparable company multiples.

A hedge fund evaluates a distressed industrial company with negative free cash flow initially. The model projects a 5-year recovery with improving EBITDA margins toward industry median, uses a high WACC of 15% to reflect risk, and models integration costs as a deduction. Sensitivity analysis focuses on WACC and terminal value assumptions to assess downside scenarios.

Suitable for SaaS or service businesses with predictable cash flows. Revenue projections start from last reported subscription revenue, applying declining growth rates. EBITDA margins converge toward industry medians, and terminal value uses exit multiple method with EV/EBITDA multiples common in tech sectors.

Ideal for capital-intensive industries like manufacturing or energy. Revenue based on production volumes and pricing, with CapEx set at 8-12% of revenue per industry norms. Depreciation is modeled as a percentage of CapEx, and working capital changes are tied to revenue deltas using historical averages.

Used for early-stage companies in sectors like biotech or cleantech. Revenue projections assume rapid initial growth declining toward terminal, with negative FCF in early years. WACC incorporates a size premium of 2-4%, and sensitivity analysis tests high WACC ranges against optimistic terminal growth assumptions.